|
Status |
Public on Oct 16, 2021 |
Title |
Identification of pharmacologic inhibitors and activators of IL-4-induced macrophage polarization [THP-1 ChIP-seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
Macrophages polarize towards different subpopulations with distinct and partly antagonistic functions in various diseases. IFNγ/LPS-polarized M1-type macrophages can have antiangiogenic activity, whereas IL-4-induced M2-type macrophages can be proangiogenic and profibrotic. Therapeutic strategies to inhibit M2-type polarization while promoting M1-type polarization could serve to inhibit pathological angiogenesis and fibrosis. Here, by combining global quantitative time-course proteomics and phosphoproteomics with a small-molecule inhibitor screen we identify signaling events that promote specifically IL-4-induced and not IFNγ/LPS-induced macrophage polarization and found that the MEK inhibitor trametinib and the HDAC inhibitor panobinostat potently prevent M2-type macrophage polarization without inhibiting M1-type polarization. In contrast, selective B-Raf inhibition promotes M2-type polarization. Trametinib and panobinostat also blocked M2-type macrophage polarization and concomitantly angiogenesis and fibrosis in models of wound healing and neovascular age-related macular degeneration in vivo. Thus, these pharmacologic inhibitors could be utilized therapeutically to selectively block IL4-induced macrophage polarization and reduce pathologic angiogenesis and fibrosis.
|
|
|
Overall design |
THP-1 cell M1-type and M2-type polarizations
|
|
|
Contributor(s) |
He L, Marneros AG |
Citation(s) |
34731634 |
|
Submission date |
Jul 13, 2020 |
Last update date |
Dec 31, 2021 |
Contact name |
Alexander G Marneros |
E-mail(s) |
[email protected]
|
Organization name |
Massachusetts General Hospital, Harvard Medical School
|
Department |
Department of Dermatology, Cutaneous Biology Research Center
|
Street address |
13th Street
|
City |
Charlestown |
State/province |
MA |
ZIP/Postal code |
02129 |
Country |
USA |
|
|
Platforms (1) |
|
Samples (27)
|
|
This SubSeries is part of SuperSeries: |
GSE154347 |
Identification of pharmacologic inhibitors and activators of IL-4-induced macrophage polarization in PBMC and THP-1 cells |
|
Relations |
BioProject |
PRJNA645924 |
SRA |
SRP271638 |
Supplementary file |
Size |
Download |
File type/resource |
GSE154343_THP_CT_DMSO_R1.mLb.clN.bigWig |
352.7 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_CT_DMSO_R1_summits.bed.gz |
1.1 Mb |
(ftp)(http) |
BED |
GSE154343_THP_CT_PANO_R1.mLb.clN.bigWig |
318.5 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_CT_PANO_R1_summits.bed.gz |
907.1 Kb |
(ftp)(http) |
BED |
GSE154343_THP_CT_TRAM_R1.mLb.clN.bigWig |
434.6 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_CT_TRAM_R1_summits.bed.gz |
1.6 Mb |
(ftp)(http) |
BED |
GSE154343_THP_IFN_DMSO_R1.mLb.clN.bigWig |
382.6 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_IFN_DMSO_R1_summits.bed.gz |
1018.9 Kb |
(ftp)(http) |
BED |
GSE154343_THP_IFN_PANO_R1.mLb.clN.bigWig |
404.6 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_IFN_PANO_R1_summits.bed.gz |
898.4 Kb |
(ftp)(http) |
BED |
GSE154343_THP_IFN_Tram_R1.mLb.clN.bigWig |
438.1 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_IFN_Tram_R1_summits.bed.gz |
1.1 Mb |
(ftp)(http) |
BED |
GSE154343_THP_IL4_DMSO_R1.mLb.clN.bigWig |
354.3 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_IL4_DMSO_R1_summits.bed.gz |
849.3 Kb |
(ftp)(http) |
BED |
GSE154343_THP_IL4_PANO_R1.mLb.clN.bigWig |
367.6 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_IL4_PANO_R1_summits.bed.gz |
983.1 Kb |
(ftp)(http) |
BED |
GSE154343_THP_IL4_Tram_R1.mLb.clN.bigWig |
315.8 Mb |
(ftp)(http) |
BIGWIG |
GSE154343_THP_IL4_Tram_R1_summits.bed.gz |
1.1 Mb |
(ftp)(http) |
BED |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |